Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration

被引:235
作者
Shimbo, Keisuke [1 ]
Miyaki, Shigeru [1 ,2 ]
Ishitobi, Hiroyuki [2 ]
Kato, Yoshio [3 ]
Kubo, Tadahiko [1 ]
Shimose, Shoji [1 ]
Ochi, Mitsuo [1 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthoped Surg, Hiroshima, Japan
[2] Hiroshima Univ Hosp, Dept Regenerat Med, Hiroshima, Japan
[3] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058566, Japan
关键词
Exosome; miR-143; Osteosarcoma cells; Delivery system; MESENCHYMAL STEM-CELLS; CANCER-CELLS; DELIVERY; VESICLES; MECHANISM;
D O I
10.1016/j.bbrc.2014.02.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs (miRNAs) have emerged as potential anticancer agents, but their clinical application is limited by the lack of an effective delivery system to tumors. Exosomes are small vesicles that play important roles in intercellular communication. Here, we show that synthetic miR-143 introduced into cells is released enveloped in exosomes and that the secreted exosome-formed miR-143 is transferred to osteosarcoma cells. The delivery of exosome-formed miR-143 significantly reduced the migration of osteosarcoma cells. The delivery efficiency of exosome-formed miR-143 was less than that achieved with lipofection, but the migratory potential of osteosarcoma cells was similarly inhibited after both strategies. Our results suggest that exosomes can deliver synthetic miR-143 and are a potentially efficient and functional delivery system. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:381 / 387
页数:7
相关论文
共 30 条
  • [1] Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
    Alvarez-Erviti, Lydia
    Seow, Yiqi
    Yin, HaiFang
    Betts, Corinne
    Lakhal, Samira
    Wood, Matthew J. A.
    [J]. NATURE BIOTECHNOLOGY, 2011, 29 (04) : 341 - U179
  • [2] microRNAs: Tiny regulators with great potential
    Ambros, V
    [J]. CELL, 2001, 107 (07) : 823 - 826
  • [3] Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
    Arroyo, Jason D.
    Chevillet, John R.
    Kroh, Evan M.
    Ruf, Ingrid K.
    Pritchard, Colin C.
    Gibson, Donald F.
    Mitchell, Patrick S.
    Bennett, Christopher F.
    Pogosova-Agadjanyan, Era L.
    Stirewalt, Derek L.
    Tait, Jonathan F.
    Tewari, Muneesh
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (12) : 5003 - 5008
  • [4] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
    Bartel, David P.
    [J]. CELL, 2007, 131 (04) : 11 - 29
  • [5] MicroRNA signatures in human cancers
    Calin, George A.
    Croce, Carlo M.
    [J]. NATURE REVIEWS CANCER, 2006, 6 (11) : 857 - 866
  • [6] Camussi G, 2011, AM J CANCER RES, V1, P98
  • [7] Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs
    Chen, Tian Sheng
    Lai, Ruenn Chai
    Lee, May May
    Choo, Andre Boon Hwa
    Lee, Chuen Neng
    Lim, Sai Kiang
    [J]. NUCLEIC ACIDS RESEARCH, 2010, 38 (01) : 215 - 224
  • [8] de Vrij J, 2013, NANOMEDICINE-UK, V8, P1443, DOI [10.2217/NNM.12.173, 10.2217/nnm.12.173]
  • [9] siRNA delivery using peptide transduction domains
    Eguchi, Akiko
    Dowdy, Steven F.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2009, 30 (07) : 341 - 345
  • [10] Current treatment of osteosarcoma
    Ferguson, WS
    Goorin, AM
    [J]. CANCER INVESTIGATION, 2001, 19 (03) : 292 - 315